Silver Book

Silver Book Fact

Identifying individuals at high risk for developing AFib

Using simple bedside measures, identification of individuals at risk for developing atrial fibrillation is feasible. Selecting high-risk individuals for inclusion in atrial fibrillation prevention trials may also enhance prevention strategies.

Schnabel R, Sullivan L, Levy D, Pencina M, et al. Development of a Risk Score for Atrial Fibrillation (Framingham Heart Study): A community-based cohort study. Lancet. 2009; 373(9665): 739-45. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2809%2960443-8/abstract

Reference

Title
Development of a Risk Score for Atrial Fibrillation (Framingham Heart Study): A community-based cohort study
Publication
Lancet
Publication Date
2009
Authors
Schnabel R, Sullivan L, Levy D, Pencina M, et al
Volume & Issue
Volume 373, Issue 9665
Pages
739-45
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Effect of optimal anticoagulation
    If 50% of atrial fibrillation patients who currently receive warfarin in routine medical care were optimally anticoagulated, 9,852 emboli would be prevented and $1.3 billion would be saved each year.  
  • AFib practice guidelines reduce direct health care costs
    The use of practice guidelines in atrial fibrillation (AF) patients significantly decreased hospitalization and resource utilization—with an average decrease in 30-day total direct health care costs of around $1,400 per patient.  
  • Aspirin use in AFib patients
    Meta-analysis of a number of randomized controlled trials found that aspirin use in atrial fibrillation patients reduced stroke risk by an average 22%.  
  • Stroke prevention through optimal anticoagulation
    If half of atrial fibrillation patients who currently receive warfarin in a routine care setting had their anti-coagulation optimized, around 9,000 strokes and more than 29,000 bleeds would be prevented.  
  • Effectiveness of pacemaker/defibrillators to control AFib
    Widespread use of pacemaker/defibrillators to control atrial fibrillation could result in a 50% decrease in stroke.